Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-08-21

Clinical Trial Update: Fixed Low-dose Heparin Versus Standard Adjusted-dose Heparin Infusion in Adults Receiving Venovenous ECMO With a Heparin Bonded Circuit. [NA]

View source ↗

Summary

A clinical trial comparing fixed low-dose heparin with standard adjusted-dose heparin in adults on venovenous ECMO with a heparin-bonded circuit was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Heparin (unfractionated heparin)

Snippet

Sponsor: University of Arizona | Conditions: Acute Respiratory Failure, Extracorporeal Membrane Oxygenation Complication | NA | Status: WITHDRAWN